High urgency

Epyrifenacil; Pesticide Tolerances

Detected July 5, 2026 · in Dietary-Supplement Labeling (FDA)

FDA established new pesticide tolerances for epyrifenacil on corn, rapeseed, soybean, and wheat. This directly impacts dietary supplement manufacturers using these crops as ingredients, as they must ensure raw materials comply with the new tolerance levels to avoid adulteration.

Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 5, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Supplement brands, contract manufacturers, private-label sellers, and ingredient suppliers using corn, rapeseed, soybean, or wheat derivatives. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately; enforcement begins upon publication (June 30, 2026).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

New maximum residue limits (tolerances) for epyrifenacil on specified crops, effective immediately upon publication.

Who it affects

Supplement brands, contract manufacturers, private-label sellers, and ingredient suppliers using corn, rapeseed, soybean, or wheat derivatives.

What you must do

Verify that all incoming lots of affected crops meet the new tolerance levels; update supplier specifications and testing protocols.

Deadline

Immediately; enforcement begins upon publication (June 30, 2026).

Source: https://www.federalregister.gov/documents/2026/06/30/2026-13193/epyrifenacil-pesticide-tolerances

Never miss a change like this again

Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Dietary-Supplement Labeling (FDA)